Discounted Cash Flow (DCF) Analysis Levered
Bastide Le Confort Médical SA (BLC.PA)
32.4 €
+0.90 (+2.86%)
All numbers are in Millions, Currency in USD
Free Cash Flow
Year A/P | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Actual | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected | 2027 Projected |
Revenue | 289.05 | 338.40 | 382.71 | 444.07 | 468.30 | 528.78 | 597.06 | 674.17 | 761.23 | 859.54 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue (%) | ||||||||||
Operating Cash Flow | 50.41 | 61.02 | 47.33 | 74.36 | 56.86 | 81.14 | 91.62 | 103.45 | 116.81 | 131.89 |
Operating Cash Flow (%) | ||||||||||
Capital Expenditure | -38.28 | -34.37 | -39.79 | -46.51 | -53.27 | -58.85 | -66.45 | -75.03 | -84.72 | -95.66 |
Capital Expenditure (%) | ||||||||||
Free Cash Flow | 12.13 | 26.65 | 7.54 | 27.85 | 3.59 | 22.29 | 25.17 | 28.42 | 32.09 | 36.23 |
Weighted Average Cost Of Capital
Share price | $ 32.4 |
---|---|
Beta | 1.089 |
Diluted Shares Outstanding | 7.37 |
Cost of Debt | |
Tax Rate | 34.90 |
After-tax Cost of Debt | 1.58% |
Risk-Free Rate | |
Market Risk Premium | |
Cost of Equity | 8.656 |
Total Debt | 419.23 |
Total Equity | 238.90 |
Total Capital | 658.13 |
Debt Weighting | 63.70 |
Equity Weighting | 36.30 |
Wacc |
Build Up Free Cash Flow
Year A/P | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Actual | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected | 2027 Projected |
Revenue | 289.05 | 338.40 | 382.71 | 444.07 | 468.30 | 528.78 | 597.06 | 674.17 | 761.23 | 859.54 |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow | 50.41 | 61.02 | 47.33 | 74.36 | 56.86 | 81.14 | 91.62 | 103.45 | 116.81 | 131.89 |
Capital Expenditure | -38.28 | -34.37 | -39.79 | -46.51 | -53.27 | -58.85 | -66.45 | -75.03 | -84.72 | -95.66 |
Free Cash Flow | 12.13 | 26.65 | 7.54 | 27.85 | 3.59 | 22.29 | 25.17 | 28.42 | 32.09 | 36.23 |
WACC | ||||||||||
PV LFCF | 21.40 | 23.20 | 25.16 | 27.27 | 29.57 | |||||
SUM PV LFCF | 126.60 |
Terminal Value
Growth in perpetuity method: | |
---|---|
Long-term growth rate | |
WACC (%) | 4.15 |
Free cash flow (t + 1) | 36.96 |
Terminal Value | 1,719.03 |
Present Value of Terminal Value | 1,402.77 |
Intrinsic Value
Enterprise Value | 1,529.37 |
---|---|
Net Debt | 397.10 |
Equity Value | 1,132.27 |
Shares Outstanding | 7.37 |
Equity Value Per Share | 153.56 |